Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM. · 1987

Read Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. by Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM. (1987) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2002403.txt.

Description

Bronchud and colleagues tested in 1987 a lab-made growth factor in patients with small cell lung cancer. The factor, called G-CSF, boosts neutrophils, white cells that fight infection. Chemotherapy often wipes those cells out. Twelve patients with advanced cancer first received the factor alone by continuous infusion for five days, at five dose levels.

No toxic effects appeared from the factor itself. Neutrophil counts rose fast in all 12 patients. The new cells moved and killed bacteria normally in tests. During later chemotherapy cycles, the factor cut the period of severe neutropenia by a median of 80 percent. Six severe infections occurred in cycles without it. None occurred in cycles with it.

Catalog record

CREATORBronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM.
YEAR1987
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2002403

Browse the full library · About the Tower of Babel